Final Thoughts and Key Takeaways on Caring for Pediatric Patients With Atopic Dermatitis

In closing this pediatric atopic dermatitis discussion, experts reflect on the modern treatment landscape. Dr. Golant expresses gratitude for practicing in an era with excellent non-steroidal options like roflumilast, which have fundamentally changed her counseling and treatment sequencing. These agents offer efficacy, safety, and tolerability profiles that achieve acceptable clinical endpoints and improve the user experience for families, often serving as valuable adjuncts to systemic therapies. Achieving disease control with minimal itch and sleep disturbance using well-tolerated maintenance therapy is deeply impactful. While managing pediatric AD remains challenging due to its variable course and the need for extensive family education, these advanced topical treatments provide more effective, comfortable pathways to long-term management and improved quality of life.